Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for AGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 19.91M
March 31, 2026 19.27M
December 31, 2025 22.58M
September 30, 2025 18.66M
June 30, 2025 70.46M
March 31, 2025 -23.09M
December 31, 2024 23.67M
September 30, 2024 46.56M
June 30, 2024 18.22M
March 31, 2024 51.44M
December 31, 2023 -2.203M
September 30, 2023 -11.03M
June 30, 2023 20.03M
Date Value
March 31, 2023 -50.81M
December 31, 2022 -7.97M
September 30, 2022 -130.94M
June 30, 2022 -296.61M
March 31, 2022 -8.869M
December 31, 2021 -2.603M
September 30, 2021 -11.56M
June 30, 2021 -67.26M
March 31, 2021 -9.074M
December 31, 2020 23.27M
September 30, 2020 1.143M
June 30, 2020 -2.67M
March 31, 2020 0.319M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Astrana Health, Inc. -6.228M
Starling Oncology, Inc. -0.908M
Nakamoto, Inc. -2.257M
American Oncology Network, Inc. --
Tenet Healthcare Corp. -203.00M